<DOC>
	<DOCNO>NCT00519662</DOCNO>
	<brief_summary>This study ass safety tolerability SNS-314 advance solid tumor human .</brief_summary>
	<brief_title>Safety Tolerability Study SNS-314 Advanced Solid Tumors</brief_title>
	<detailed_description>Other objective study include measure pharmacokinetics ( long drug measure blood ) .</detailed_description>
	<criteria>Advanced solid tumor measurable scan Uncontrolled untreated central nervous system metastases Cerebrovascular accident/transient ischemic attack 6 month Cycle 1 Day 1 Any follow cardiac condition : History myocardial infarction , acute coronary syndrome 12 week Cycle 1 Day 1 Class III IV heart failure 6 month Cycle 1 Day 1 Baseline heart rate correct QT interval ( QTc ) &gt; 450 msec History ventricular arrhythmias 6 month Cycle 1 Day 1 Use medication prolong QTc interval associate Torsades de Pointe ( TdP ) Previous cancer treatment 21 day first dose Any investigational therapy 28 day Cycle 1 Day 1 Known allergy cyclodextrins Please note : There additional inclusion/exclusion criterion study . Please contact study center additional information determine study criterion meet .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Solid</keyword>
	<keyword>Tumors</keyword>
	<keyword>Advanced</keyword>
</DOC>